0001477932-23-005118.txt : 20230707
0001477932-23-005118.hdr.sgml : 20230707
20230707160222
ACCESSION NUMBER: 0001477932-23-005118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230705
FILED AS OF DATE: 20230707
DATE AS OF CHANGE: 20230707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Butera Salvatore Thomas
CENTRAL INDEX KEY: 0001834339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36833
FILM NUMBER: 231076759
MAIL ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VOLITIONRX LTD
CENTRAL INDEX KEY: 0000093314
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 911949078
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
BUSINESS PHONE: 1 (646) 650-1351
MAIL ADDRESS:
STREET 1: 1489 WEST WARM SPRINGS ROAD
STREET 2: SUITE 110
CITY: HENDERSON
STATE: NV
ZIP: 89014
FORMER COMPANY:
FORMER CONFORMED NAME: STANDARD CAPITAL CORP
DATE OF NAME CHANGE: 19990812
4
1
form4.xml
FORM 4
X0407
4
2023-07-05-05:00
false
0000093314
VOLITIONRX LTD
VNRX
0001834339
Butera Salvatore Thomas
1489 WEST WARM SPRINGS ROAD
SUITE 110
HENDERSON
NV
89014
false
true
false
false
CEO - Volition Veterinary
false
Common Stock
2023-07-05-05:00
4
A
false
28800
0.00
A
184707
D
Common Stock
61350
D
On October 4, 2022, the reporting person was awarded 64,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 28,800 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 9,600 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 11,200 RSUs and 24,000 RSUs subject to the award previously vested and remain subject to time-based vesting.
These shares of common stock are jointly owned by the reporting person and his spouse.
/s/ Salvatore Thomas Butera
2023-07-07-05:00